Compared to the control group, the Plut-treated group exhibited reduced CD68+ (macrophage) and MMP-9+ immunoreactive atherosclerosis, whereas the Dlut-treated group demonstrated the lowest macrophage infiltration and lowest MMP-9 expression among all cohorts. This evidence concerns the gene MMP9 and atherosclerosis.